SINGAPORE, Sept. 11, 2025 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received the “CDMO of the Year – Asia Pacific”, “Best Biologics CDMO Award: Bioprocessing”, and “Best…
